DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Graft-versus-host disease	R-HSA-1643685	map05332	deptropine	203911	drug-path
Olfactory transduction	R-HSA-9751605	map04740	deptropine	203911	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	deptropine	203911	drug-path
Type II diabetes mellitus	R-HSA-2127377	map04930	deptropine	203911	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	deptropine	203911	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	deptropine	203911	drug-path
Asthma	R-HSA-444620	map05310	deptropine	203911	drug-path
Graft-versus-host disease	R-HSA-1643685	map05332	ricinine	10666	drug-path
Hematopoietic cell lineage	R-HSA-173752	map04640	ricinine	10666	drug-path
Autoimmune thyroid disease	R-HSA-1643685	map05320	ricinine	10666	drug-path
Antigen processing and presentation	R-HSA-1236975	map04612	ricinine	10666	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ricinine	10666	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	ricinine	10666	drug-path
Asthma	R-HSA-444620	map05310	ricinine	10666	drug-path
Allograft rejection	R-HSA-9679028	map05330	ricinine	10666	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	ricinine	10666	drug-path
Renal cell carcinoma	R-HSA-9794523	map05211	ricinine	10666	drug-path
Natural killer cell mediated cytotoxicity	R-HSA-5218921	map04650	ricinine	10666	drug-path
Pathways in cancer	R-HSA-9824443	map05200	ricinine	10666	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	ricinine	10666	drug-path